MULTIPLE MYELOMA KNOWLEDGE CENTER

Speak to an MMRF
nurse specialist

An MMRF nurse specialist can
guide you through your multiple
myeloma journey every step of the
way. Call Monday-Friday, 9-7 ET.

CALL NOW

What is Farydak?

Farydak®, also known as panobinosat, is the first approved myeloma therapy in a class of medicines known as histone deacetylase inhibitors. Farydak is made by Novartis Pharmaceuticals.

The MMRF and it’s affiliate organization, the Multiple Myeloma Research Consortium (MMRC), played an integral role in the development of Farydak.

uses2 side effects2 dosing2 clinical studies2